Literature DB >> 6306421

Human deoxycytidylate deaminase. Substrate and regulator specificities and their chemotherapeutic implications.

W R Mancini, Y C Cheng.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6306421

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


× No keyword cloud information.
  5 in total

Review 1.  Clinical potential of elacytarabine in patients with acute myeloid leukemia.

Authors:  Lindsay A M Rein; David A Rizzieri
Journal:  Ther Adv Hematol       Date:  2014-12

2.  Cytosine arabinoside transport and metabolism in acute leukemias and T cell lymphoblastic lymphoma.

Authors:  J S Wiley; J Taupin; G P Jamieson; M Snook; W H Sawyer; L R Finch
Journal:  J Clin Invest       Date:  1985-02       Impact factor: 14.808

3.  The role of deoxycytidine-metabolizing enzymes in the cytotoxicity induced by 3'-amino-2',3'-dideoxycytidine and cytosine arabinoside.

Authors:  W R Mancini
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

4.  The human equilibrative nucleoside transporter 1 mediates in vitro cytarabine sensitivity in childhood acute myeloid leukaemia.

Authors:  I Hubeek; R W Stam; G J Peters; R Broekhuizen; J P P Meijerink; E R van Wering; B E S Gibson; U Creutzig; C M Zwaan; J Cloos; D J Kuik; R Pieters; G J L Kaspers
Journal:  Br J Cancer       Date:  2005-12-12       Impact factor: 7.640

Review 5.  Detection of Genomic Uracil Patterns.

Authors:  Angéla Békési; Eszter Holub; Hajnalka Laura Pálinkás; Beáta G Vértessy
Journal:  Int J Mol Sci       Date:  2021-04-09       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.